Cidara Therapeutics
CDTX
CDTX
66 hedge funds and large institutions have $76.2M invested in Cidara Therapeutics in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
+1
Holders Change %
+1.54%
% of All Funds
1.34%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
7
Increased
24
Reduced
19
Closed
6
Calls
$154K
Puts
$58K
Net Calls
+$96K
Net Calls Change
-$359K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.71M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$761K |
| 3 |
Goldman Sachs
New York
|
+$418K |
| 4 |
ACM
Alethea Capital Management
Mercer Island,
Washington
|
+$359K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$349K |
Top Sellers
| 1 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$720K |
| 2 |
Two Sigma Investments
New York
|
-$471K |
| 3 |
BBVA
Banco Bilbao Vizcaya Argentaria
Madrid,
Spain
|
-$323K |
| 4 |
Jane Street
New York
|
-$130K |
| 5 |
Two Sigma Advisers
New York
|
-$103K |
